Modulators of SESTRIN-GATOR2 Interaction and Uses Thereof (2016)
Supernus Pharmaceuticals, Inc.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 62/245,553, filed Oct 23, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,414,782 | Modulators of SESTRIN-GATOR2 Interaction and Uses Thereof In force · High confidence UsedRemaining | Supernus Pharmaceuticals, Inc. | In force | High confidence | ||
| US 10,752,644 | Modulators of SESTRIN-GATOR2 Interaction and Uses Thereof In force · High confidence | Supernus Pharmaceuticals, Inc. | In force | High confidence | ||
| US 11,325,924 | Modulators of SESTRIN-GATOR2 Interaction and Uses Thereof In force · Low confidence | Supernus Pharmaceuticals, Inc. | In force | Low confidence | ||
| US 10,100,066 | Modulators of SESTRIN-GATOR2 Interaction and Uses Thereof In force · High confidence | Supernus Pharmaceuticals, Inc. | In force | High confidence | ||
| US 12,378,263 | Modulators of SESTRIN-GATOR2 Interaction and Uses Thereof In force · High confidence | Supernus Pharmaceuticals, Inc. | In force | High confidence | ||
| Application 19/259,904 | Modulators of SESTRIN-GATOR2 Interaction and Uses Thereof Pending Not granted | Supernus Pharmaceuticals, Inc. | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Supernus Pharmaceuticals, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.